DRUG earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E -31.34. Updated 2026-07-23.
Bright Minds Biosciences (DRUG) Research Hub
Bright Minds Biosciences (DRUG) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 51.09 USD (-2.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -31.34, market cap 0.59B. This hub links to the full technical, earnings and options research available for DRUG.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 51.09 USD (-2.65%) |
| 52-week range | 47.23 USD – 87 USD |
| Trend regime | Range |
| 14-day RSI | 55.1 (Bullish) |
| Trailing P/E | -31.34 |
| Market cap | 0.59B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for DRUG
Covered Call on DRUG: how it works, illustrative setup around the real 51.09 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on DRUG: how it works, illustrative setup around the real 51.09 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on DRUG: how it works, illustrative setup around the real 51.09 USD price, max profit/loss, breakeven and when to use it. Educational.
DRUG technical analysis: range, last 51.09 USD, RSI 55.1, 52w range 47.23 USD–87 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is DRUG in?
Bright Minds Biosciences (DRUG) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is DRUG in an uptrend or downtrend?
As of 2026-10-26, DRUG is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is DRUG's trailing P/E ratio?
DRUG's trailing P/E is -31.34, with a market cap of 0.59B. See the earnings research page for full valuation detail.
When does DRUG next report earnings?
DRUG is next scheduled to report earnings on 2026-08-13.